Science Writer & Researcher
Nicolás Mario Lisnovsky is a fourth-year Biology student at the University of Buenos Aires (UBA), Argentina. He is currently working as a research trainee at CONICET. During his academic training, he has carried out research activities in different laboratories at UBA, including InMiBo and INQUIMAE. In parallel, he has actively participated in several science outreach initiatives, such as public workshops and demonstration stands. His main scientific interests focus on molecular engineering and synthetic biology. He is also strongly motivated by science communication as a way to highlight the value of science in society.
16
Published articles
Disorders of Gut–Brain Interaction (DGBIs), such as Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS), present a formidable clinical impasse due to their profoundly heterogeneous and multifactorial nature.
For the elite athlete, an injury is more than a clinical setback, it is an existential interruption. The pursuit of physical excellence has long been haunted by the inherent fragility of the human frame, where a single ligament tear or a chronic strain can dismantle years of disciplined optimization. Historically
In elite triathlon, the swim and bike segments are often viewed as the "decisive" moments. However, the data reveals a far more lopsided reality. According to García-González et al. (2026), running is the ultimate "great separator.
We have all witnessed the physiological "decoupling" that occurs late in a race, where at mile 20 of a marathon, a pace that felt like a metabolic steady-state two hours ago suddenly demands an all-out effort.
Professional cycling is a sport defined by marginal gains. At the highest levels of competition, the difference between victory and the middle of the pack can be measured in seconds, watts, or subtle physiological advantages accumulated over months of preparation.
article discusses how plant synthetic biology is reshaping biofortification strategies, particularly through approaches such as heterologous pathway engineering and transporter-based redistribution
The human ear is often described as one of the most sophisticated sensory systems in biology. Within a structure no larger than a seashell, the auditory system can detect frequencies ranging from the faint rumble of distant thunder to the subtle harmonic texture of a violin string
The current trajectory of epilepsy management has encountered a formidable "refractory wall." Despite the accelerated expansion of the neuropharmacological pharmacopeia,
Cells can be understood as highly coordinated systems in which DNA functions as a comprehensive but inert blueprint, requiring precise interpretation to become biologically active. Gene expression depends on regulatory proteins that orchestrate transcription across time and space.
What if one of the most powerful models for understanding the human brain were less than an inch long, transparent, and living in a small tank? Meet Danio rerio, the zebrafish.
Understanding the human brain remains one of the greatest challenges in modern science. With billions of neurons forming intricate networks and constantly changing connections, the brain’s complexity makes it extremely difficult to study directly.
Evolution is often imagined as a process that unfolds over millions of years. However, in microorganisms such as yeasts, evolutionary changes can occur much more rapidly. Yeasts reproduce quickly, populations grow to large sizes, and genetic variations can spread through generations in a short time.
In this study, I explore how cancer risk is distributed across the animal kingdom, emphasizing the role of life-history traits, reproductive strategies, and social behavior in shaping susceptibility to disease. Drawing on recent findings in comparative oncology, the article examines patterns that challenge traditional assumptions, such as the relationship between body size and cancer, and highlights evolutionary mechanisms that may confer resistance in certain species.
Cells constantly sense signals from their environment and convert them into internal actions through biochemical signalling pathways.
This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.
Selective oxidation reactions are central to modern biochemistry. They enable the controlled introduction of oxygen into organic molecules, a key step in the synthesis of pharmaceuticals and fine chemicals. However, many of the enzymatic systems traditionally used for these transformations are complex and difficult to implement in practice.
